20-hydroxyeicosatetraenoic acid (20-HETE) protects glomerular protein permeability barrier from focal segmental glomerulosclerosisi (FSGS) factor.

被引：0
|
作者：
McCarthy, ET
Sharma, R
Roman, RJ
Sharma, M
机构：
[1] Med Coll Wisconsin, Div Nephrol, Milwaukee, WI 53226 USA
[2] Vet Affairs Med Ctr, Div Nephrol, Kansas City, MO USA
[3] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：84A / 84A
页数：1
相关论文
共 46 条
  • [21] ω-Oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4
    Collins, XH
    Harmon, SD
    Kaduce, TL
    Berst, KB
    Fang, X
    Moore, SA
    Raju, TV
    Falck, JR
    Weintraub, NL
    Duester, G
    Plapp, BV
    Spector, AA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (39) : 33157 - 33164
  • [22] Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells
    Colombero, Cecilia
    Papademetrio, Daniela
    Sacca, Paula
    Mormandi, Eduardo
    Alvarez, Elida
    Nowicki, Susana
    HORMONES & CANCER, 2017, 8 (04): : 243 - 256
  • [23] 20-Hydroxyeicosatetraenonic acid (20-HETE) is required to maintain integrity of glomerular protein permeabililty barrier
    McCarthy, E
    Reddy, S
    Savin, VJ
    Sharma, M
    HYPERTENSION, 2005, 46 (04) : 879 - 879
  • [24] Signaling pathways involved in the effects of 20-hydroxyl analogs of 20-hydroxyeicosatetraenoic acid (20-HETE) in the rat preglomerular vessel
    Hercule, HC
    Oyekan, AO
    FASEB JOURNAL, 2003, 17 (04): : A70 - A70
  • [25] 20-hydroxyeicosatetraenoic acid (20-HETE) is a pivotal endogenous ligand for TRPV1-mediated neurogenic inflammation in the skin
    Hamers, Alexander
    Primus, Christopher P.
    Whitear, Charlotte
    Kumar, Nitin Ajit
    Masucci, Michael
    Moreira, Shanik A. Montalvo
    Rathod, Krishnaraj
    Chen, Jianmin
    Bubb, Kristen
    Colas, Romain
    Khambata, Rayomand S.
    Dalli, Jesmond
    Ahluwalia, Amrita
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (07) : 1450 - 1469
  • [26] CYP4A isoform expression and 20-hydroxyeicosatetraenoic acid (20-HETE) synthesis in renal preglomerular arteries.
    Marji, JS
    Wang, MH
    Laniado-Schwartzman, M
    FASEB JOURNAL, 2000, 14 (04): : A576 - A576
  • [27] 20-Hydroxyeicosatetraenoic acid protects the pulmonary vasculature from apoptosis
    Bodiga, Sreedhar
    Dunn, Laurel K.
    Gao, Ying
    Gruenloh, Stephanie K.
    Buonaccorsi, Noelle J.
    Al-Saghir, Rula
    Falck, John R.
    Medhora, Meetha M.
    Jacobs, Elizabeth R.
    FASEB JOURNAL, 2008, 22
  • [28] Effect of TS-011, an inhibitor of the synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE), on infarct size in models of ischemic stoke
    Tanaka, Y
    Omura, T
    Miyata, N
    Kitano, K
    Koizumi, C
    Fukasawa, M
    Endou, H
    Hachiuma, K
    Minagawa, T
    Yoshida, S
    Nakaike, S
    Okuyama, S
    Roman, RJ
    Harder, DR
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 292P - 292P
  • [29] 20-Hydroxyeicosatetraenoic acid (20-HETE) and endothelin-1 (ET-1) modulation of vascular function is increased in aging
    Berezan, DJF
    Falck, JR
    Davidge, ST
    FASEB JOURNAL, 2005, 19 (05): : A1677 - A1677
  • [30] 20-hydroxyeicosatetraenoic acid (20-HETE) stimulates NF-κB activation and the production of inflammatory cytokines in human endothelial cells
    Ishizuka, T.
    Ogawa, S.
    Mori, T.
    Nako, K.
    Ito, O.
    Schwartzman, M. L.
    Ito, S.
    JOURNAL OF HYPERTENSION, 2008, 26 : S304 - S305
12345